[Factors affecting development of sudden death and risk stratification of patients after myocardial infarction].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A O Nesterko.
Explore the source record for details and available documents.
The authors have analyzed their experiences with treatment of 50 patients with ischemic heart disease using transplantation of autologous mono-nuclears of the bone marrow. It was shown that this operation resulted in an improvement of indices of the heart functions and myocardium metabolism. Transplantation of stem cells as mononuclear fraction of the bone marrow is indicated in treatment of different groups of patients: in recurrent diseases after previous operations on the coronary arteries; in patients with distal lesions of the coronary bed; transplantation of autologous stem cells of the bone marrow is expedient simultaneously with coronary artery bypass grafting or coronary angioplasty (stenting).
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The course of the disease and the dunamics of immunologic shifts were compared in 277 patients suffering from myocardial infarction, 87 of whom had foci of infection and chronic infectious-allergic diseases while 190 had no complications. In patients of the first group the disease was usually of a lingering character and anticardiac antibodies were found in circulation for lengthy periods of time. The incidence of chronic tonsillitis and odontogenous infectious foci was higher among patients with myocardial infarction complicated by the postinfarction syndrome than among those with a noncomplicated course of the disease (in 12 out of 20 and in 3 out of 20 patients, respectively).
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.